FDA Letter API

Medina Baking and Powder Products, Inc.

Letter data

Company
Medina Baking and Powder Products, Inc.
Recipient
Mr. Roberto Martin | President | Medina Baking and Powder Products, Inc. | 1864 NW 22nd Street | Miami | , | FL | 33142-7444 | United States | rmartin@medinabaking.com
Issue date
2024-01-10
Posted date
Not available
FDA office
Office of Human and Animal Food Operations Division IV East
Subject
Not available
Product
Dietary Supplements
CMS ID
619373
Reference number
24-HAFE4-WLCOL-01
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Medina Baking and Powder Products, Inc. MARCS-CMS 619373 — January 10, 2024 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA Electronic Mail Reference #: 24-HAFE4-WLCOL-01 Product: Dietary Supplements Recipient: Recipient Name Mr. Roberto Martin Recipient Title President Medina Baking and Powder Products, Inc. 1864 NW 22nd Street Miami , FL 33142-7444 United States rmartin@medinabaking.com Issuing Office: Office of Human and Animal Food Operations Division IV East United States Secondary Issuing Offices United States Dear Mr. Roberto Martin: The Food and Drug Administration has completed evaluation of your firm’s corrective actions in response to our Warning Letter, 22-HAFE4-WL-03 dated March 4, 2022. Based on our evaluation It appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Pearl E. Lopina -S Pearl Lopina Digitally signed by Pearl E. Lopina -S Date: 2024.01.10 14:35:33 -05'00' Director of Compliance Branch OHAFO, Division IV East Content current as of: 01/12/2024 Regulated Product(s) Dietary Supplements